TGX-221

TGX-221

Catalog Number:
L002368434APE
Mfr. No.:
APE-A2681
Price:
$204
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          TGX-221 is a potent inhibitor of (phosphatidylinositol 3-kinases) PI3K which specifically inhibits PI3K -p110β isoform with IC50 value of 8.5 nM [1].In J774.2 macrophage cells, TGX-221 has been demonstrated to reduce insulin-induced phosphorylation of Ser473 of protein kinase B (PKB). While in in CHO-IR and 3T3-L1 cells, TGX-221 has no effect on PKB phosphprylation [1].In vivo, TGX-221 significantly improved blood flow in FeCl3-induced arterial thrombosis as well as increased tail and renal bleeding times in mice. In addition, TGX-221 has revealed to disrupt CFRs in a Folts model of arterial thrombosis in male Sprague-Dawley rats [2].

          [1] Chaussade C1, Rewcastle GW, Kendall JD, Denny WA, Cho K, Gr nning LM, Chong ML, Anagnostou SH,Jackson SP, Daniele N, Shepherd PR. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem J. 2007 Jun 15;404(3):449-58.
          [2] Bird JE1, Smith PL, Bostwick JS, Shipkova P, Schumacher WA. Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-β inhibitor in mice. Thromb Res. 2011 Jun;127(6):560-4.

      • Properties
        • Alternative Name
          9-(1-anilinoethyl)-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one
          CAS Number
          663619-89-4
          Molecular Formula
          C21H24N4O2
          Molecular Weight
          364.44
          Purity
          98.00%
          Solubility
          insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL in DMSO with gentle warming
          Storage
          Store at -20°C

          * For Research Use Only

    We Also Recommend

    10Panx

    $180

    10Panx

    $238

    Butein

    $231

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.